Assertio (ASRT) Set to Announce Earnings on Monday

Assertio (NASDAQ:ASRT) is scheduled to be issuing its quarterly earnings data after the market closes on Monday, May 6th. Analysts expect the company to announce earnings of ($0.01) per share for the quarter. Parties that wish to register for the company’s conference call can do so using this link.

Assertio (NASDAQ:ASRT) last announced its quarterly earnings data on Monday, March 11th. The company reported $0.08 EPS for the quarter. The firm had revenue of $32.99 million during the quarter, compared to analyst estimates of $31.42 million. Assertio had a negative net margin of 218.28% and a positive return on equity of 6.30%. On average, analysts expect Assertio to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Assertio Stock Performance

Shares of Assertio stock opened at $1.03 on Friday. The firm has a market capitalization of $97.97 million, a P/E ratio of -0.26 and a beta of 1.00. The company has a quick ratio of 1.43, a current ratio of 1.83 and a debt-to-equity ratio of 0.28. The company has a 50 day moving average price of $0.92 and a 200 day moving average price of $1.11. Assertio has a 52 week low of $0.73 and a 52 week high of $8.01.

About Assertio

Assertio Holdings, Inc, a commercial pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis.